JOHN N BONFIGLIO
CIK 1222253 · President and COO · last filed 2017-03-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$238.9K
Companies
2
Total Filings
14
Lifetime Open-Market Net
$1.7K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Marker Therapeutics, Inc. (TPIV) Delisted | President and COO | 36,471 | — | — | $0 | 2 | 2017-03-13 |
| OGEN | President and CEO | 385,255 | $0.62 | $238.9K | $1.7K | 3 | 2014-08-13 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2011-09-30 | — | Grant (A) | — | $0 | |
| 2011-08-16 | — | Buy (P) | +1,250 | $2.7K | |
| 2011-05-26 | — | Grant (A) | — | $0 | |
| 2010-10-22 | — | Grant (A) | +50,000 | $40.0K |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.